Given the established role of GINS2 in proliferation and its overexpression in multiple cancers, coupled with the critical influence of the immune microenvironment in OSCC, we hypothesized that GINS2 functions as a key driver of OSCC progression by not only promoting tumor cell growth and invasion but also by actively shaping an immunosuppressive TME. Here, GINS2 is linked to neoplasm.